KIA LAMBETH: Open Payments
NPI 1033622295 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 90 payments from 22 companies in 2025. Trend: 2023 $1,487 · 2024 $1,502 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $317 |
| ABBVIE INC. | 16 | $231 |
| Novo Nordisk Inc | 14 | $205 |
| Lilly USA, LLC | 11 | $137 |
| Corcept Therapeutics | 6 | $124 |
| Abbott Laboratories | 4 | $86 |
| Astellas Pharma US Inc | 3 | $80 |
| Almatica Pharma LLC | 3 | $65 |
| Lundbeck LLC | 4 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
Products named: BREZTRI, UBRELVY, Korlym, Ozempic, REXULTI, MOUNJARO, FREESTYLE LIBRE 3, QULIPTA.
Industry payments across AZ — which companies pay providers there.
